Last update 23 Jan 2025

Sanofi Winthrop LP

Subsidiary Company|
New Jersey, United States
|
www.winthropus.com

Overview

Related

13
Drugs associated with Sanofi Winthrop LP
Tiludronate Disodium
Target
PTPs
Mechanism
PTPs inhibitors
Active Org.
SanofiSanofi [+1]
Originator Org.
SanofiSanofi
Active Indication
Osteitis Deformans
Inactive Indication
Osteoporosis, Postmenopausal
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
FR
First Approval Date01 Jan 1995
WIN-57273
Target
Top II
Mechanism
Top II inhibitors [+1]
Active Org.
University of PennsylvaniaUniversity of Pennsylvania
Originator Org.
Sanofi Winthrop LP
Active Indication
Bacterial Infections
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Amifloxacin mesylate
Target
Top II
Mechanism
Top II inhibitors
Active Org.
Sterling Winthrop, Inc.
Originator Org.
SanofiSanofi
Active Indication
Bacterial Infections
Inactive Indication
Gram-Negative Bacterial Infections [+2]
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Sanofi Winthrop LP
Login to view more data
0 Patents (Medical) associated with Sanofi Winthrop LP
Login to view more data
100 Deals associated with Sanofi Winthrop LP
Login to view more data
100 Translational Medicine associated with Sanofi Winthrop LP
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
13
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Medorinone
 ( PDE3 )		Heart Failure
More
Discontinued
WIN-33377
 ( Top II )		Solid tumor
More
Discontinued
WIN 65579
 ( PDE5A )		Cardiovascular Diseases
More
Discontinued
Amifloxacin mesylate
 ( Top II )		Gram-Negative Bacterial Infections
More
Discontinued
WIN-57273
 ( Top II )		Bacterial Infections
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free